This is read by an automated voice. Please report any issues or inconsistencies here. Lily Collins is ready for her reservation at Tiffany’s. The actor will play Audrey Hepburn in a new movie about ...

Lily Collins will play Audrey Hepburn in a new movie about the making of the 1961 classic “Breakfast at Tiffany’s.” Collins will also serve as a producer for the project, which is based on the Sam ...

Eli Lilly LLY-1.01%decrease; red down pointing triangle received approval from the Food and Drug Administration for a label expansion of its weight-loss drug Zepbound, adding a new monthly delivery ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

Lily Collins' latest role has been a long time coming. The "Emily in Paris" star, 36, is set to play legendary actress Audrey Hepburn in an upcoming movie about the making of the classic film ...

Determined to avoid a repeat of the supply shortfalls that plagued early GLP-1 rollouts for obesity, Eli Lilly has amassed a sizable store of its oral weight loss candidate orforglipron. Specifically, ...

An Army soldier at Fort Hood in Killeen, Texas, says he's grateful to be alive thanks to some fellow soldiers who came to his aid on the side of a road while he was having a medical emergency. U.S.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eli Lilly and Co. is buying a ...

As the 2026 Winter Olympics get underway in Italy this week, Eli Lilly—a partner of both Team USA and the Milan Cortina Games as a whole—is rolling out a new corporate campaign inspired by the event.

Eli Lilly’s stock closed 10.3% higher on Wednesday after the drug giant reported triple-digit growth of Zepbound and Mounjaro, its game-changing weight-loss and Type 2 diabetes drugs. That’s the third ...

Eli Lilly posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. The ...